Eric D. Eisenmann

543 total citations
31 papers, 271 citations indexed

About

Eric D. Eisenmann is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Eric D. Eisenmann has authored 31 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Hematology. Recurrent topics in Eric D. Eisenmann's work include Acute Myeloid Leukemia Research (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Eric D. Eisenmann is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Drug Transport and Resistance Mechanisms (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Eric D. Eisenmann collaborates with scholars based in United States, Netherlands and Italy. Eric D. Eisenmann's co-authors include Sharyn D. Baker, Alex Sparreboom, Zahra Talebi, Yan Jin, Phillip R. Zoladz, Boyd R. Rorabaugh, Albert Bui, Shuiying Hu, Daelynn R. Buelow and Alice A. Gibson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Eric D. Eisenmann

28 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric D. Eisenmann United States 11 84 82 53 35 31 31 271
Sang Kyu Park South Korea 12 165 2.0× 63 0.8× 82 1.5× 8 0.2× 6 0.2× 44 448
Shohei Yamamoto Japan 12 148 1.8× 50 0.6× 111 2.1× 4 0.1× 33 1.1× 50 374
Xiadi Zhou United States 5 144 1.7× 71 0.9× 24 0.5× 18 0.5× 9 0.3× 5 398
Paul Waeltz United States 7 135 1.6× 95 1.2× 15 0.3× 38 1.1× 4 0.1× 14 385
Ken Tsumiyama Japan 10 124 1.5× 68 0.8× 22 0.4× 8 0.2× 10 0.3× 23 455
J. B. G. Bell United Kingdom 13 192 2.3× 41 0.5× 73 1.4× 50 1.4× 28 0.9× 34 474
Xin-zheng Lu China 12 124 1.5× 27 0.3× 10 0.2× 5 0.1× 15 0.5× 31 320
Giusy Messina Italy 9 105 1.3× 80 1.0× 8 0.2× 15 0.4× 7 0.2× 36 368
Francisco H C Felix Brazil 10 87 1.0× 28 0.3× 26 0.5× 3 0.1× 40 1.3× 30 314
Cheryl Galindo United States 6 162 1.9× 133 1.6× 7 0.1× 8 0.2× 29 0.9× 11 432

Countries citing papers authored by Eric D. Eisenmann

Since Specialization
Citations

This map shows the geographic impact of Eric D. Eisenmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Eisenmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Eisenmann more than expected).

Fields of papers citing papers by Eric D. Eisenmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Eisenmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Eisenmann. The network helps show where Eric D. Eisenmann may publish in the future.

Co-authorship network of co-authors of Eric D. Eisenmann

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Eisenmann. A scholar is included among the top collaborators of Eric D. Eisenmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Eisenmann. Eric D. Eisenmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yue, Eman Ahmed, Kevin M. Huang, et al.. (2025). Strain-dependent neuronal disposition and toxicity of paclitaxel in mice. 1. 100005–100005. 1 indexed citations
2.
Huang, Kevin M., Peter de Bruijn, Mahesh R. Nepal, et al.. (2024). Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen. Cancer Research Communications. 4(9). 2489–2497. 2 indexed citations
3.
4.
Talebi, Zahra, Yan Jin, Alice A. Gibson, et al.. (2024). Darolutamide does not interfere with OATP‐mediated uptake of docetaxel. International Journal of Cancer. 155(2). 314–323. 3 indexed citations
5.
Talebi, Zahra, Eric D. Eisenmann, Kalindi Parmar, et al.. (2023). Exploring pharmacokinetics of talazoparib in ABCB1/ABCG2-deficient mice using a novel UHPLC-MS/MS method. Heliyon. 9(11). e20972–e20972.
6.
Eisenmann, Eric D. & Alex Sparreboom. (2023). Unique Cabozantinib Dosing Considerations in People Living with HIV and Cancer. Clinical Cancer Research. 29(24). 4999–5001.
7.
Eisenmann, Eric D., Kevin M. Huang, Daelynn R. Buelow, et al.. (2022). TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion. Cancers. 15(1). 29–29. 7 indexed citations
8.
Buelow, Daelynn R., Bhavana Bhatnagar, Shelley Orwick, et al.. (2022). BMX kinase mediates gilteritinib resistance inFLT3-mutated AML through microenvironmental factors. Blood Advances. 6(17). 5049–5060. 7 indexed citations
9.
Jin, Yan, Zahra Talebi, Shuiying Hu, et al.. (2022). Itraconazole-Induced Increases in Gilteritinib Exposure Are Mediated by CYP3A and OATP1B. Molecules. 27(20). 6815–6815. 5 indexed citations
10.
Li, Yang, Yan Jin, Keith T. Schmidt, et al.. (2022). A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug–Drug Interaction Liabilities. Pharmaceutics. 14(9). 1933–1933. 5 indexed citations
11.
Eisenmann, Eric D., Zahra Talebi, Yan Jin, et al.. (2022). Interaction of Antifungal Drugs with CYP3A- and OATP1B-Mediated Venetoclax Elimination. Pharmaceutics. 14(4). 694–694. 12 indexed citations
12.
Eisenmann, Eric D., Qiang Fu, Yan Jin, et al.. (2021). Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A Inhibition. Cancer Research Communications. 1(2). 79–89. 12 indexed citations
13.
Eisenmann, Eric D., Zahra Talebi, Alex Sparreboom, & Sharyn D. Baker. (2021). Boosting the oral bioavailability of anticancer drugs through intentional drug–drug interactions. Basic & Clinical Pharmacology & Toxicology. 130(S1). 23–35. 34 indexed citations
14.
Talebi, Zahra, et al.. (2020). Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. Pharmaceutics. 12(9). 856–856. 31 indexed citations
15.
Buelow, Daelynn R., Mingshan Niu, Eric D. Eisenmann, et al.. (2020). TP-0903 is active in models of drug-resistant acute myeloid leukemia. JCI Insight. 5(23). 21 indexed citations
16.
Hussaarts, Koen G. A. M., Leni van Doorn, Karel Eechoute, et al.. (2020). Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib. Pharmaceutics. 12(9). 788–788. 10 indexed citations
17.
Eisenmann, Eric D., et al.. (2020). Development and validation of a sensitive UHPLC-MS/MS analytical method for venetoclax in mouse plasma, and its application to pharmacokinetic studies. Journal of Chromatography B. 1152. 122176–122176. 16 indexed citations
18.
Inaba, Hiroto, John C. Panetta, Stanley Pounds, et al.. (2019). Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies. Clinical Cancer Research. 25(24). 7320–7330. 15 indexed citations
19.
20.
Eisenmann, Eric D., Boyd R. Rorabaugh, & Phillip R. Zoladz. (2016). Acute Stress Decreases but Chronic Stress Increases Myocardial Sensitivity to Ischemic Injury in Rodents. Frontiers in Psychiatry. 7. 71–71. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sang Kyu Park Breakdown of academic impact, for papers by Shohei Yamamoto Breakdown of academic impact, for papers by Xiadi Zhou Breakdown of academic impact, for papers by Paul Waeltz Breakdown of academic impact, for papers by Ken Tsumiyama Breakdown of academic impact, for papers by J. B. G. Bell Breakdown of academic impact, for papers by Xin-zheng Lu Breakdown of academic impact, for papers by Giusy Messina Breakdown of academic impact, for papers by Francisco H C Felix Breakdown of academic impact, for papers by Cheryl Galindo
Rankless by CCL
2026